Oxazepam Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg, 15 mg, 30 mg
Reference Brands: Sobril®(EU)
Category:
Antipsychotropic Drugs
Oxazepam is a benzodiazepine that enhances the effect of GABA (gamma-aminobutyric acid) at GABA-A receptors, leading to sedative, anxiolytic, and muscle-relaxant effects. It is primarily used for the management of anxiety disorders, short-term relief of anxiety symptoms, and treatment of alcohol withdrawal symptoms. Its slower onset and metabolism make it suitable for elderly patients and those with liver impairment.
Oxazepam Tablets is available in Tablets
and strengths such as 10 mg, 15 mg, 30 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Oxazepam Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Oxazepam Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Oxazepam tablets are FDA-approved in the United States for the management of anxiety disorders and for the short-term relief of anxiety symptoms, including anxiety associated with depression and acute alcohol withdrawal. As a Schedule IV controlled substance, U.S. regulations require CNS depressant labeling, abuse potential warnings, and compliance with GMP standards for manufacturing. In the European Union, oxazepam is approved under various brand names through national marketing authorizations, often for anxiety and insomnia. EU regulations include Risk Management Plans (RMPs) and mandatory pharmacovigilance. For dossier-ready Oxazepam tablet supply and B2B sourcing, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing